(JPM) JPMorgan Chase - NYSE
Sector: Financial Services | Industry: Banks - Diversified | Exchange: NYSE (USA) | Market Cap: 840.000m USD | Total Return: 23.4% in 12m
Avg Turnover: 2.44B
EPS Trend: 92.7%
Qual. Beats: 1
Rev. Trend: 88.6%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
JPMorgan Chase & Co. is a global financial services holding company headquartered in New York. Founded in 1799, the firm operates through three primary segments: Consumer & Community Banking, Commercial & Investment Bank, and Asset & Wealth Management. Its diversified business model provides a broad range of services, including retail and commercial banking, investment banking, and multi-asset investment management solutions across North America, Europe, the Middle East, Africa, and Asia.
As a Global Systemically Important Bank (G-SIB), JPMorgan Chase is subject to stringent capital requirements and regulatory oversight designed to maintain stability within the international financial system. The company generates revenue through both net interest income from lending activities and non-interest income from advisory fees, trading commissions, and asset management charges. Diversified banks often benefit from economies of scope, utilizing a vast physical branch network alongside digital platforms to cross-sell products to a global client base ranging from individual consumers to sovereign governments.
For more detailed insights into the companys valuation and performance metrics, you may want to consult ValueRay. Investors should monitor how interest rate fluctuations and global credit cycles impact the firms diverse revenue streams.
- Net interest income fluctuates based on Federal Reserve benchmark rate adjustments
- Investment banking fees depend on global equity and debt capital market activity
- Credit card delinquency rates impact loan loss provision requirements and earnings
- Basel III endgame capital requirements threaten long-term return on equity targets
- Cross-border transaction volume shifts drive global corporate payments and treasury revenue
| Net Income: 58.9b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 6.08 > 1.0 |
| NWC/Revenue: -497.0% < 20% (prev -533.4%; Δ 36.36% < -1%) |
| CFO/TA 0.03 > 3% & CFO 141b > Net Income 58.9b |
| Net Debt (-631b) to EBITDA (83.8b): -7.52 < 3 |
| Current Ratio: 0.62 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.79b) vs 12m ago -1.08% < -2% |
| Gross Margin: 60.87% > 18% (prev 58.78%; Δ 2.08% > 0.5%) |
| Asset Turnover: 6.16% > 50% (prev 6.27%; Δ -0.12% > 0%) |
| Interest Coverage Ratio: 0.76 > 6 (EBIT TTM 74.7b / Interest Expense TTM 98.1b) |
| A: -0.29 (Total Current Assets 2291b - Total Current Liabilities 3708b) / Total Assets 4900b |
| B: 0.09 (Retained Earnings 428b / Total Assets 4900b) |
| C: 0.02 (EBIT TTM 74.7b / Avg Total Assets 4629b) |
| D: 0.08 (Book Value of Equity 364b / Total Liabilities 4536b) |
| Altman-Z'' = -1.42 = CCC |
| DSRI: 1.15 (Receivables 427b/357b, Revenue 285b/273b) |
| GMI: 0.97 (GM 58.78% / 60.87%) |
| AQI: 0.91 (AQ_t 0.52 / AQ_t-1 0.57) |
| SGI: 1.04 (Revenue 285b / 273b) |
| TATA: -0.02 (NI 58.9b - CFO 141b) / TA 4900b) |
| Beneish M = -2.96 (Cap -4..+1) = A |
As of June 15, 2026, the stock is trading at USD 320.72 with a total of 5,312,833 shares traded.
Over the past week, the price has changed by +2.67%,
over one month by +6.82%,
over three months by +13.73% and
over the past year by +23.40%.
JPMorgan Chase has received a consensus analysts rating of 3.88. Therefore, it is recommended to buy JPM.
- StrongBuy: 8
- Buy: 7
- Hold: 9
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 342.2 | 6.7% |
P/E Trailing = 15.0139
P/E Forward = 14.1044
P/S = 4.8399
P/B = 2.408
P/EG = 1.641
Revenue TTM = 285b USD
EBIT TTM = 74.7b USD
EBITDA TTM = 83.8b USD
Long Term Debt = 449b USD (from longTermDebt, last quarter)
Short Term Debt = 785b USD (from shortTermDebt, last quarter)
Debt = 1233b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -631b USD (calculated: Debt 1233b - CCE 1864b)
Enterprise Value = 209b USD (840b + Debt 1233b - CCE 1864b)
Interest Coverage Ratio = 0.76 (Ebit TTM 74.7b / Interest Expense TTM 98.1b)
EV/FCF = 1.48x (Enterprise Value 209b / FCF TTM 141b)
FCF Yield = 67.36% (FCF TTM 141b / Enterprise Value 209b)
FCF Margin = 49.44% (FCF TTM 141b / Revenue TTM 285b)
Net Margin = 20.66% (Net Income TTM 58.9b / Revenue TTM 285b)
Gross Margin = 60.87% ((Revenue TTM 285b - Cost of Revenue TTM 112b) / Revenue TTM)
Gross Margin QoQ = 64.25% (prev 59.11%)
Tobins Q-Ratio = 0.04 (Enterprise Value 209b / Total Assets 4900b)
Interest Expense / Debt = 7.96% (Interest Expense 98.1b / Debt 1233b)
Taxrate = 21.12% (15.8b / 74.7b)
NOPAT = 58.9b (EBIT 74.7b * (1 - 21.12%))
Current Ratio = 0.62 (Total Current Assets 2291b / Total Current Liabilities 3708b)
Debt / Equity = 3.39 (Debt 1233b / totalStockholderEquity, last quarter 364b)
Debt / EBITDA = -7.52 (Net Debt -631b / EBITDA 83.8b)
Debt / FCF = -4.48 (Net Debt -631b / FCF TTM 141b)
Total Stockholder Equity = 361b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.27% (Net Income 58.9b / Total Assets 4900b)
RoE = 16.32% (Net Income TTM 58.9b / Total Stockholder Equity 361b)
RoCE = 9.22% (EBIT 74.7b / Capital Employed (Equity 361b + L.T.Debt 449b))
RoIC = 3.00% (NOPAT 58.9b / Invested Capital 1963b)
WACC = 7.55% (E(840b)/V(2073b) * Re(9.41%) + D(1233b)/V(2073b) * Rd(7.96%) * (1-Tc(0.21)))
Discount Rate = 9.41% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -93.09 | Cagr: -1.93%
[DCF] Terminal Value 75.44% ; FCFF base≈141b ; Y1≈142b ; Y5≈150b
[DCF] Fair Price = 1.11k (EV 2332b - Net Debt -631b = Equity 2963b / Shares 2.68b; r=8.35% [WACC [floored]]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: 92.73 | EPS CAGR: 10.64% | SUE: 1.18 | # QB: 1
Revenue Correlation: 88.55 | Revenue CAGR: 13.46% | SUE: 0.75 | # QB: 0
EPS current Quarter (2026-06-30): EPS=5.39 | Chg30d=+0.11% | Revisions=+25% | Analysts=15
EPS next Quarter (2026-09-30): EPS=5.43 | Chg30d=-0.58% | Revisions=+25% | Analysts=15
EPS current Year (2026-12-31): EPS=22.31 | Chg30d=+0.12% | Revisions=+73% | GrowthEPS=+13.1% | GrowthRev=+7.8%
EPS next Year (2027-12-31): EPS=23.55 | Chg30d=+0.17% | Revisions=+73% | GrowthEPS=+5.6% | GrowthRev=+4.0%
[Analyst] Revisions Ratio: +73%